Roivant Sciences Ltd.

NASDAQ: ROIVW · Real-Time Price · USD
2.75
0.12 (4.56%)
At close: Jan 16, 2025, 10:00 PM

Roivant Sciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
2.72B 6.54B 1.68B 2.06B
Short-Term Investments
2.17B 5.37M 5.01M n/a
Long-Term Investments
302.94M 247.75M 304.32M 325.83M
Other Long-Term Assets
32.86M 39.11M 49.48M 25.82M
Receivables
n/a 82.81M 37.64M 6.73M
Inventory
n/a 35.25M 2.76M n/a
Other Current Assets
113.17M 17.59M 20.44M 26.02M
Total Current Assets
5B 6.73B 1.8B 2.15B
Property-Plant & Equipment
101.08M 65.95M 92.34M 86.95M
Goodwill & Intangibles
n/a 137.84M 144.88M n/a
Total Long-Term Assets
436.88M 490.65M 591.02M 438.61M
Total Assets
5.44B 7.22B 2.39B 2.59B
Account Payables
23.69M 53.23M 37.83M 34.58M
Deferred Revenue
1.17M 4.17M 12.44M 10.15M
Short-Term Debt
n/a 12M 40.72M n/a
Other Current Liabilities
53.93M 85.94M 74.84M 83.98M
Total Current Liabilities
149.41M 266.76M 272.45M 184.37M
Long-Term Debt
n/a 430.59M 375.51M 210.03M
Other Long-Term Liabilities
10M 29.34M 80.58M 53.09M
Total Long-Term Liabilities
100.33M 507.19M 509.57M 339.33M
Total Liabilities
249.74M 773.95M 782.02M 523.7M
Total Debt
100.17M 499.75M 481.4M 283.89M
Common Stock
n/a n/a n/a n/a
Retained Earnings
116.06M 576.17M -3.77B -2.76B
Comprehensive Income
9.44M -4.08M -2.62M -946K
Shareholders Equity
4.69B 5.97B 1.16B 1.66B
Total Investments
2.47B 247.75M 304.32M 325.83M